导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 33.79% | 113/1050 |
| 近一周 | -2.95% | 779/1104 |
| 近一月 | -4.87% | 624/1102 |
| 近一季 | -3.16% | 493/1092 |
| 近半年 | 17.99% | 167/1070 |
| 近一年 | 34.10% | 136/1018 |
| 近两年 | 78.72% | 297/926 |
| 近三年 | 25.13% | 440/833 |
| 成立以来 | 17.86% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.77% 153/1070 |
55.32% 197/1101 |
- - |
- - |
| 2025 | 20.65% 655/1065 |
-2.89% 947/1014 |
-2.75% 878/1038 |
37.09% 247/1050 |
-6.81% 789/1065 |
| 2024 | -15.11% 860/1011 |
-10.89% 792/960 |
-5.91% 685/983 |
9.87% 628/991 |
-7.85% 818/1011 |
| 2023 | -16.06% 567/952 |
12.36% 75/880 |
-8.74% 720/895 |
-9.50% 568/915 |
-9.55% 838/952 |
| 2022 | -25.29% 505/867 |
-21.65% 620/773 |
-2.99% 738/806 |
-8.13% 149/845 |
7.00% 136/867 |
| 2021 | 11.15% 230/740 |
3.87% 65/580 |
2.01% 514/659 |
-1.08% 233/704 |
6.04% 180/740 |
| 2020 | 31.95% 339/554 |
-4.78% 282/419 |
15.54% 341/466 |
14.07% 162/517 |
5.13% 437/554 |
| 2019 | - - |
- - |
- - |
0.03% 330/390 |
7.58% 258/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 嘉实长青竞争优势股票A VS. 东吴新产业精选股票A(580008) |